CCL13 anticorps
Aperçu rapide pour CCL13 anticorps (ABIN6260535)
Antigène
Voir toutes CCL13 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- CCL13 Antibody detects endogenous levels of total CCL13
-
Réactivité croisée
- Humain, Souris, Rat (Rattus)
-
Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
-
Immunogène
- A synthesized peptide derived from human CCL13
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB 1:1000-3000 IHC 1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C.Stable for 12 months from date of receipt
-
Date de péremption
- 12 months
-
-
- CCL13 (Chemokine (C-C Motif) Ligand 13 (CCL13))
-
Autre désignation
- CCL13
-
Sujet
-
Description: Chemotactic factor that attracts monocytes, lymphocytes, basophils and eosinophils, but not neutrophils. Signals through CCR2B and CCR3 receptors. Plays a role in the accumulation of leukocytes at both sides of allergic and non-allergic inflammation. May be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis. May play a role in the monocyte attraction in tissues chronically exposed to exogenous pathogens.
Gene: CCL13
-
Poids moléculaire
- 11 kDa
-
ID gène
- 6357
-
UniProt
- Q99616
-
Pathways
- Regulation of Systemic Arterial Blood Pressure by Hormones, Phosphorylation & l'infection par le SRAS-CoV-2
Antigène
-